DMS Imaging: Sustained Growth and Encouraging Results in 2023 and the First Quarter of 2024

DMS Imaging, a key player in the field of medical imaging systems, announced growth of 15% in its turnover in 2023, reaching 40.6 million euros. This progression is in line with expectations, supported by a notable strengthening in the bone densitometry sector, which saw its activity increase by 50% to reach 9.0 million euros.

In the geographic market, DMS Imaging consolidated its presence in Europe with a 4% increase in turnover, while the American market recorded a doubling of its revenues. Operating income remained stable, close to break-even, with EBITDA margins improved to 6.4% compared to 5.7% in 2022.

For the first quarter of 2024, despite a cyberattack having slightly slowed production, the company generated a turnover of 9.4 million euros. The new Platinum Neo table, launched in 2023, is now fully operational and ready to contribute positively to future financial results.

DMS Imaging is also focusing on innovation with the Platinum radiology table and plans increases in gross margin as well as the implementation of structuring projects according to their strategic plan for 2027.